REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sahasra Pharma Chem Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Sahasra Pharma Chem Private Limited Profile Updated: January 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Sahasra Pharma Chem Private Limited is an unlisted company, incorporated on 31/07/2020. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24231TG2020PTC142336 and registration number is 142336.

Headquarters
P No. 226 S No. 223 & 224 Phase Iii Industrial Park Patancheru(M) Sangareddy Dist Pashamylaram Medak In-Ts In 502307
Sangareddy; Telangana; Postal Code: 502307

Contact Details: Purchase the Sahasra Pharma Chem Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Sahasra Pharma Chem Private Limited report to view the information.
Financial Auditors:
Purchase the Sahasra Pharma Chem Private Limited report to view the information.
Incorporation Date:
July 31, 2020
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Sahasra Pharma Chem Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
20.58%▲
Total operating revenue
29.5%▲
Operating profit (EBIT)
232.71%▲
EBITDA
180.36%▲
Net Profit (Loss) for the Period
313.25%▲
Total Assets
48.85%▲
Total Equity
35.86%▲
Operating Profit Margin (ROS)
11.32%▲
Net Profit Margin
8.98%▲
Return on Equity (ROE)
17.71%▲
Debt/Equity
19.78%▲
Quick Ratio
0.18%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo